Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5746772 | 0.98 | MAPT (0.40) | KDM4EGAAMAPTSIGMAR1CYP1A2 | |
| SCHEMBL5747124 | 0.94 | CYP3A4 (0.40) | KDM4EGAAMAPTSIGMAR1CYP1A2 | |
| SCHEMBL5745827 | 0.92 | KDM4E (0.39) | KDM4EGAAMAPTSIGMAR1CYP1A2 | |
| SCHEMBL13967904 | 0.86 | KDM4E (0.32) | KDM4EGAAMAPTSIGMAR1 | |
| SCHEMBL16376115 | 0.86 | HTR2A (0.34) | KDM4EGAAMAPTSIGMAR1HTR2A | |
| SCHEMBL13967928 | 0.86 | KDM4E (0.32) | KDM4EGAAMAPTSIGMAR1 | |
| SCHEMBL13967975 | 0.85 | SIGMAR1 (0.45) | SIGMAR1CYP1A2CYP3A4ALDH1A1HPGD | |
| SCHEMBL13967926 | 0.85 | KDM4E (0.34) | KDM4EGAAMAPTSIGMAR1CYP1A2 | |
| SCHEMBL13967982 | 0.84 | KDM4E (0.33) | KDM4EGAAMAPTSIGMAR1 | |
| SCHEMBL13967970 | 0.82 | SIGMAR1 (0.33) | KDM4EGAAMAPTSIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404299-B2 | Method for producing peptide compound comprising highly sterically hindered amino acid | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-02 | — | — | US | claimed |
| CN-114630835-B | Process for the preparation of peptide compounds comprising sterically bulky amino acids | 中外制药株式会社 | 2025-02-11 | — | — | CN | claimed |
| CN-119362542-A | Electric automobile group charging method based on cooperative optimization of traffic network and micro-grid | 湖南工业大学 | 2025-01-24 | — | — | CN | claimed |
| EP-4486459-A1 | HUMANIZED 3E10 ANTIBODIES, VARIANTS, AND ANTIGEN BINDING FRAGMENTS THEREOF | Yale University (US) | 2025-01-08 | — | — | EP | claimed |
| US-20240421302-A1 | OLIVINE COMPOSITE CATHODE MATERIAL, PREPARATION METHOD AND APPLICATION THEREOF, AND LITHIUM-ION BATTERY | BEIJING EASPRING MATERIAL TECHNOLOGY CO., LTD. (CN) | 2024-12-19 | — | — | US | claimed |
| EP-4468404-A1 | OLIVINE COMPOSITE POSITIVE-ELECTRODE MATERIAL, PREPARATION METHOD AND APPLICATION THEREOF, AND LITHIUM-ION BATTERY | Beijing Easpring Material Technology Co., Ltd. (CN) | 2024-11-27 | — | — | EP | claimed |
| WO-2023168352-A1 | HUMANIZED 3E10 ANTIBODIES, VARIANTS, AND ANTIGEN BINDING FRAGMENTS THEREOF | YALE UNIVERSITY (US) | 2023-09-07 | — | — | WO | claimed |
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-01-26 | — | — | US | claimed |
| CN-115358783-A | Multi-electric vehicle and multi-micro-grid multi-party game energy trading system based on reinforcement learning and multiple constraints | 湖南工业大学 | 2022-11-18 | — | — | CN | claimed |
| EP-4056580-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-09-14 | — | — | EP | claimed |
| CN-114630835-A | Process for the preparation of peptide compounds comprising sterically bulky amino acids | 中外制药株式会社 | 2022-06-14 | — | — | CN | claimed |
| EP-4225822-B1 | METHOD FOR PRODUCING POLYURETHANE FOAMS OR HYDROGELS BY EMPLOYING DIOL CONTAINING FORMULATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4678652-A1 | METHOD FOR PRODUCING CYCLIC PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-12404299-B2 | Method for producing peptide compound comprising highly sterically hindered amino acid | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-02 | — | — | US | disclosed |
| EP-4570813-A1 | METHOD FOR PRODUCING N-SUBSTITUTED AMINO ACID RESIDUE-CONTAINING CYCLIC PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-18 | — | — | EP | disclosed |
| US-20090186993-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-1990371-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-11-12 | — | — | EP | disclosed |
| US-20070173557-A1 | Dental material based on alkoxysilyl-functional polyethers containing a salt of a strong base as catalyst | KETTENBACH GMBH & CO. KG (DE) | 2007-07-26 | — | — | US | disclosed |
| US-20070173557-A1 | Dental material based on alkoxysilyl-functional polyethers containing a salt of a strong base as catalyst | KETTENBACH GMBH & CO. KG (DE) | 2007-07-26 | — | — | US | disclosed |
| EP-1738737-A1 | Dimensionally stable articles from cured condensation-crosslinked dental material | Kettenbach GmbH & CO. KG (DE) | 2007-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173557-A1 | Dental material based on alkoxysilyl-functional polyethers containing a salt of a strong base as catalyst | CSNK1A1L, TBL3, DCLK3 | KDM4E 3211/4885GAA 2438/4885MAPT 2308/4885 |
| US-20230026641-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | DNPEP, VIP, NPEPPS | KDM4E 4275/4885GAA 1224/4885MAPT 2810/4885 |
| US-12404299-B2 | Method for producing peptide compound comprising highly sterically hindered amino acid | DNPEP, VIP, NPEPPS | KDM4E 4275/4885GAA 1224/4885MAPT 2810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.